TITLE

Valenta Pharm slices net losses in Q1

AUTHOR(S)
Interfax
PUB. DATE
May 2013
SOURCE
Russia & CIS Business & Financial Newswire;5/14/2013, p1
SOURCE TYPE
Newswire
DOC. TYPE
Article
ABSTRACT
MOSCOW. May 14 (Interfax) - OJSC Valenta Pharm reduced its net losses to Russian Accounting Standards 74.3% year-on-year in the first quarter of 2013 to 25.97 million rubles, the company reported.
ACCESSION #
87594977

 

Related Articles

  • Valenta Pharm sees net loss soar 42.4% in H1. Interfax // Central Asia General Newswire;8/12/2013, p1 

    MOSCOW. Aug 12 (Interfax) - Valenta Pharm saw its net loss to Russian Accounting Standards increase by 42.4% year-on-year to 106.644 million rubles in the first half of 2013, the drug maker reported.

  • Valenta Pharm sees net loss soar 42.4% in H1. Interfax // Russia & CIS Business & Financial Newswire;8/12/2013, p1 

    MOSCOW. Aug 12 (Interfax) - Valenta Pharm saw its net loss to Russian Accounting Standards increase by 42.4% year-on-year to 106.644 million rubles in the first half of 2013, the drug maker reported.

  • Valenta Pharm swings to profit of 119.8 mln rubles in Q1. Interfax // Russia & CIS Business & Financial Newswire;5/13/2014, p1 

    MOSCOW. May 13 (Interfax) - OJSC Valenta Pharm had net profit to Russian Accounting Standards (RAS) of 119.805 million rubles in January-March 2014 versus loss of 25.965 million rubles a year before, the company said in a report.

  • Valenta Pharm swings to net profit of 505 mln rubles in H1. Interfax // Russia & CIS Business & Financial Newswire;8/14/2014, p1 

    MOSCOW. Aug 14 (Interfax) - OJSC Valenta Pharm had net profit to Russian Accounting Standards (RAS) of 505 million rubles in the first half of the year versus loss of 106 million rubles a year ago, the company said in a report.

  • Valenta Pharm ups net profit 160% in Jan-Sept 2013. Interfax // Russia & CIS Business & Financial Newswire;11/13/2013, p1 

    MOSCOW. Nov 13 (Interfax) - OJSC Valenta Pharm upped net profit to Russian Accounting Standards (RAS) 160% year-on-year in January-September 2013 to 928.36 million rubles, the company reported.

  • Valenta Pharm shareholders waive dividends for 2013. Interfax // Russia & CIS Business & Financial Newswire;7/2/2014, p1 

    MOSCOW. July 2 (Interfax) - Shareholders in OJSC Valenta Pharm voted to waive dividends for 2013 at the AGM, the company said in a statement.

  • Valenta Pharm to buy back 10% of shares for 1,500 rubles per share. Interfax // Russia & CIS Business & Financial Newswire;2/ 3/2014, p1 

    MOSCOW. Feb 3 (Interfax) - OJSC Valenta Pharm will buy back ordinary shares for 1,500 rubles per share, the drug maker said in a statement.

  • Valenta Pharm board of directors recommends against 2013 dividends. Interfax // Russia & CIS Business & Financial Newswire;5/14/2014, p1 

    MOSCOW. May 14 (Interfax) - The board of directors of OJSC Valenta Pharm recommended shareholders not pay out dividends for 2013 at a board meeting on May 13, the company said in a statement.

  • Dish Loses 134,000 Viewers. Investor's Business Daily // Investors Business Daily;5/12/2015, pA01 

    8 Despite the net loss of viewers in Q1, satellite TV broadcaster

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics